Repare Therapeutics RPTX

$ 1.36 2.65%

Quarterly report 2024-Q3
added 11-07-2024

Repare Therapeutics Financial Statements 2011-2024 | RPTX

Annual Financial Statements Repare Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	279 M	422 M	608 M	1.37 B	-	-	-	-	-	-	-	-	-
Shares	42.1 M	41.9 M	37.8 M	36.8 M	-	-	-	-	-	-	-	-	-
Historical Prices	6.62	10.1	16.1	32.9	-	-	-	-	-	-	-	-	-
Net Income	-93.8 M	-29 M	-107 M	-53.4 M	-27.2 M	-14.3 M	-7.8 M	-	-	-	-	-	-
Revenue	-	-	-	135 K	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-116 M	-19.8 M	-109 M	-54.3 M	-26.4 M	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-114 M	-17.8 M	-107 M	-53.4 M	-25.8 M	-12.4 M	-6.07 M	-	-	-	-	-	-
Operating Expenses	167 M	152 M	116 M	54.4 M	26.4 M	12.8 M	6.18 M	-	-	-	-	-	-
General and Administrative Expenses	33.8 M	32.6 M	26.2 M	14.3 M	5.38 M	2.91 M	1.77 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Repare Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	42.5 M	42.4 M	42.2 M	42.2 M	42.1 M	42.1 M	42 M	42 M	41.9 M	41.9 M	41.9 M	41.9 M	37.1 M	37 M	36.9 M	36.9 M	36.8 M	4.83 M	1.63 M	1.53 M	1.53 M	1.53 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-34.4 M	-34.8 M	13.2 M	-	-18.9 M	-11.9 M	-34.9 M	-	75.5 M	-38.1 M	-34.8 M	-	-30.9 M	-26.3 M	-21.4 M	-	-38.2 M	-24.4 M	-12.6 M	-	-18.9 M	-11.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-36.4 M	-37.3 M	10.8 M	-	-38.4 M	-12.3 M	-34.7 M	-	73.4 M	-38.7 M	-34.8 M	-	-31.7 M	-26.7 M	-21.6 M	-	-14.1 M	-12.3 M	-10.8 M	-	-6.87 M	-5.88 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	11.3 M	-	-	-	-34.2 M	-	74.9 M	-38.7 M	-34.3 M	-	-30.6 M	-26.7 M	-21.3 M	-	-13.5 M	-11.9 M	-10.6 M	-	-6.45 M	-5.62 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	36.4 M	38.4 M	41.6 M	-	40.6 M	42.5 M	40.4 M	-	39.1 M	39.4 M	35.2 M	-	32 M	26.9 M	21.7 M	-	14.1 M	12.3 M	10.8 M	-	6.87 M	5.88 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	6.44 M	8.32 M	8.62 M	-	7.87 M	8.72 M	8.53 M	-	7.9 M	7.94 M	8.78 M	-	6.6 M	6.74 M	5.24 M	-	4 M	3.37 M	2.18 M	-	1.25 M	1.03 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency